Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 788Terminated 197Unknown 103Recruiting 101Withdrawn 60Active not recruiting 58Not yet recruiting 22Suspended 3No longer available 3Enrolling by invitation 2Available 1Approved for marketing 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 7Lymphoid 3Myeloid 2Sarcoma 1Other 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma 9Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell 5Leukemia, Lymphocytic, Chronic, B-Cell 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell 4Lymphoma, Follicular 4Leukemia, Myeloid, Acute 4Immunoblastic Lymphadenopathy 4Hematologic Neoplasms 4Lymphoma, T-Cell, Peripheral 3Leukemia 3Recurrence 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Hodgkin Disease 2Dendritic Cell Sarcoma, Interdigitating 2Burkitt Lymphoma 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Spondylolisthesis 1Spinal Stenosis 1Small Cell Lung Carcinoma 1Sarcoma 1Rectal Neoplasms 1Neurotoxicity Syndromes 1Neoplasms by Histologic Type 1

Interventions

ponatinib 1Vincristine 1RFB4(dsFv)-PE38 recombinant immunotoxin 1Prednisolone 1Methylprednisolone 1Methotrexate 1Inotuzumab Ozogamicin 1Injections 1Dexamethasone 1Dasatinib 1Cytarabine 1Calcium Dobesilate 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Suspended × Leukemia × Lymphoid × Clear all
NCT04747912 2026-03-30

Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)

University of Chicago

Phase 2 Suspended
25 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00991744 2012-10-10

Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)

Nordic Society for Pediatric Hematology and Oncology

Phase 3 Suspended
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Neurotoxicity Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00077493 2007-12-28

BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

MedImmune LLC

Phase 1 Suspended
95 enrolled
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡